Cargando…
Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG)
BACKGROUND: Vestibular migraine (VM) is the most frequent cause of recurrent spontaneous attacks of vertigo causally related to migraine. The objective of the Prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG) trial was to demonstrate that metoprolol succinate is superior to pl...
Autores principales: | Bayer, Otmar, Adrion, Christine, Al Tawil, Amani, Mansmann, Ulrich, Strupp, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937687/ https://www.ncbi.nlm.nih.gov/pubmed/31888723 http://dx.doi.org/10.1186/s13063-019-3903-5 |
Ejemplares similares
-
Prophylactic treatment of vestibular migraine()
por: Salmito, Márcio Cavalcante, et al.
Publicado: (2016) -
Efficacy and safety of betahistine treatment in patients with Meniere’s disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial)
por: Adrion, Christine, et al.
Publicado: (2016) -
Current Treatment Options in Vestibular Migraine
por: Obermann, Mark, et al.
Publicado: (2014) -
Bayesian model selection techniques as decision support for shaping a statistical analysis plan of a clinical trial: An example from a vertigo phase III study with longitudinal count data as primary endpoint
por: Adrion, Christine, et al.
Publicado: (2012) -
A randomized double-blind, placebo-controlled, cross-over trial (Vestparoxy) of the treatment of vestibular paroxysmia with oxcarbazepine
por: Bayer, Otmar, et al.
Publicado: (2017)